THE CHINWAGY BUZZ
Lilly and NVIDIA expand AI drug-discovery collaboration through co-innovation lab
THE COLLABORATION
What to know
and where to go.
Lilly and NVIDIA are developing a co-innovation lab combining AI computing, scientific expertise and large-scale data to accelerate medicine discovery. The initiative is supported by up to $1 billion in combined investment over five years.
- Availability
- Started 2026-03-31; the official source does not state an end date.
- Place
- San Francisco, United States
EXPLORE MORE